Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  voriconazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-22 of 22 for your search:
Start Over
Antifungal Use in Oncohematological Neutropenic Patients
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 2 and over
Sponsor: Other
Protocol IDs: 2005-004973-55, ANTIVORIFUNGOL, NCT00386802
Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A1501038, NCT00143312
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NA_00041916, NCT01416025
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: Other
Protocol IDs: EORTC-19961, PFIZER-150-307-000, NCT00003031
Phase III Randomized Study of Voriconazole Compared to Liposomal Amphotericin B as Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia (Summary Last Modified 09/1999)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-98-C-0063, PFIZER-150-603
Phase III Study of Voriconazole in Patients With Invasive Fungal Infections (Summary Last Modified 01/2001)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: NCI-99-C-0094B, NCI-99-C-0094
Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A1501029, NCT00150345
Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 2 to 12
Sponsor: NCI, NHLBI
Protocol IDs: 416, BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A8851009, NCT00531479
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0443, NCT00904995
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9766-CL-0104, WSA-CS-004, 2006-003868-59, NCT00412893
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 2 and over
Sponsor: NCI
Protocol IDs: CDR0000298887, NCI-03-C-0111, NCT00059878
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 2 to 11
Sponsor: NCI
Protocol IDs: CDR0000316329, NCI-03-C-0218, NCT00066599
Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0536, NCT00418951
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 2 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: A1501096, NCT01383993
Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy
Phase: Phase II
Type: Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 13_DOG06_172, 2013-002578-34, NCT01887457
Phase I Study of Voriconazole versus Fluconazole in Patients with Hematologic Malignancies, Hematologic Conditions, or Solid Tumors at Risk for Aspergillosis (Summary Last Modified 10/98)
Phase: Phase I
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MCV-CCHR-9603-2H, PFIZER-95CK39-0673, NCI-G97-1325
Phase I Study of Voriconazole in Children Who Require Treatment for the Prevention of Systemic Fungal Infection (Summary Last Modified 03/2001)
Phase: Phase I
Type: Supportive care
Status: Completed
Age: 2 to 12
Sponsor: NCI
Protocol IDs: NCI-00-C-0150
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 8 and over
Sponsor: NCI
Protocol IDs: 060198, 06-C-0198, NCT00353158
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000355116, P30CA016042, UCLA-0307071, NCT00079222
Blood and Marrow Transplant Clinical Research Network
Phase: No phase specified
Type: Supportive care, Treatment
Status: Completed
Age: 2 and over
Sponsor: NHLBI
Protocol IDs: 139, NCT00023530
An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: PMH-VOR, NCT01321372
Start Over